Intravenous Infusions Plc (GHSE:IIL)
0.0400
0.00 (0.00%)
At close: Aug 6, 2025
Intravenous Infusions Balance Sheet
Financials in millions GHS. Fiscal year is January - December.
Millions GHS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 1.49 | 0.29 | 0.95 | 0.81 | 0.96 | Upgrade
|
Cash & Short-Term Investments | 1.49 | 0.29 | 0.95 | 0.81 | 0.96 | Upgrade
|
Cash Growth | 405.98% | -69.17% | 18.07% | -16.05% | 41.03% | Upgrade
|
Accounts Receivable | 10.23 | 15.07 | 15.13 | 15.74 | 14.17 | Upgrade
|
Other Receivables | 2.41 | 1.44 | 1.77 | 1.79 | 2.21 | Upgrade
|
Receivables | 12.63 | 16.51 | 16.9 | 17.53 | 16.37 | Upgrade
|
Inventory | 6.09 | 6.26 | 6.63 | 7.65 | 6.06 | Upgrade
|
Prepaid Expenses | 0.06 | 0.09 | 0.07 | 0.09 | 0.08 | Upgrade
|
Total Current Assets | 20.26 | 23.15 | 24.55 | 26.08 | 23.48 | Upgrade
|
Property, Plant & Equipment | 24.5 | 23.26 | 22.21 | 20.41 | 13.79 | Upgrade
|
Long-Term Investments | 0.01 | 0.01 | - | - | - | Upgrade
|
Other Intangible Assets | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | Upgrade
|
Total Assets | 44.84 | 46.49 | 46.82 | 46.55 | 37.33 | Upgrade
|
Accounts Payable | 12.21 | 9.33 | 8.52 | 7.1 | 3.62 | Upgrade
|
Accrued Expenses | 0.05 | 0.18 | 0.18 | 0.2 | 0.29 | Upgrade
|
Short-Term Debt | 0.87 | 1.23 | 1.64 | - | - | Upgrade
|
Current Portion of Long-Term Debt | 3.94 | 3.94 | 4.09 | 2.54 | 3.87 | Upgrade
|
Current Portion of Leases | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | Upgrade
|
Current Income Taxes Payable | - | 0 | - | - | - | Upgrade
|
Other Current Liabilities | 7.31 | 6.15 | 6.96 | 4.15 | 3.08 | Upgrade
|
Total Current Liabilities | 24.4 | 20.86 | 21.4 | 14 | 10.87 | Upgrade
|
Long-Term Debt | 3.94 | 7.88 | 10.36 | 13.81 | 8.06 | Upgrade
|
Long-Term Leases | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.55 | 0.39 | 0.25 | 0.41 | 0.42 | Upgrade
|
Total Liabilities | 28.93 | 29.17 | 32.04 | 28.26 | 19.39 | Upgrade
|
Common Stock | 11.63 | 11.63 | 11.63 | 11.63 | 11.63 | Upgrade
|
Additional Paid-In Capital | 2.1 | 2.1 | 2.1 | 2.1 | 2.1 | Upgrade
|
Retained Earnings | 2.18 | 3.59 | 1.05 | 4.56 | 4.21 | Upgrade
|
Shareholders' Equity | 15.91 | 17.32 | 14.78 | 18.29 | 17.94 | Upgrade
|
Total Liabilities & Equity | 44.84 | 46.49 | 46.82 | 46.55 | 37.33 | Upgrade
|
Total Debt | 8.81 | 13.12 | 16.13 | 16.39 | 11.97 | Upgrade
|
Net Cash (Debt) | -7.32 | -12.83 | -15.18 | -15.58 | -11.01 | Upgrade
|
Net Cash Per Share | -0.03 | -0.05 | -0.06 | -0.06 | -0.04 | Upgrade
|
Filing Date Shares Outstanding | 274.41 | 274.41 | 274.41 | 274.41 | 274.41 | Upgrade
|
Total Common Shares Outstanding | 274.41 | 274.41 | 274.41 | 274.41 | 274.41 | Upgrade
|
Working Capital | -4.14 | 2.29 | 3.15 | 12.08 | 12.61 | Upgrade
|
Book Value Per Share | 0.06 | 0.06 | 0.05 | 0.07 | 0.07 | Upgrade
|
Tangible Book Value | 15.84 | 17.25 | 14.72 | 18.23 | 17.88 | Upgrade
|
Tangible Book Value Per Share | 0.06 | 0.06 | 0.05 | 0.07 | 0.07 | Upgrade
|
Land | 3.74 | 3.74 | 3.74 | 2.66 | 2.66 | Upgrade
|
Machinery | 8.79 | 8.74 | 5.59 | 5.48 | 5.37 | Upgrade
|
Construction In Progress | 18.12 | 16.31 | 17.63 | 16.41 | 9.36 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.